About 6,630,000 results
Open links in new tab
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced …
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V.
Twice-yearly shot proves successful at preventing HIV infection …
Long-acting injectable lenacapavir continues to show promising …
Gilead Lenacapavir cut HIV infections by 96% in trial
New HIV drug can only offer hope of ending AIDS if all have …
Long-acting injectable lenacapavir proves effective in HIV …
Full Efficacy and Safety Results for Gilead Investigational Twice ...
Gilead Shot Provides Total Protection From HIV in Trial of Young ...
Twice-a-year injection reduced risk of HIV infection by 96%, drug …